By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
DNTVDNTV
Notification Show More
Aa
  • Home
  • News
    News
    Delaware Newsline endeavors to share stories that challenge dominant narratives, bring context and nuance to complex issues, and support and uplift communities in need.
    Show More
    Top News
    1
    Gallery: Were you seen at the 2018 Delaware Mud Run?
    08/16/2021
    Murder is the second leading cause of death among American teenagers
    06/23/2022
    More than 32,000 Delawareans May Be Eligible for Stimulus Payments
    10/05/2022
    Latest News
    In spite of not having a newspaper photographer, the William Penn HS Graduation Ceremony Still Went On
    06/07/2023
    Delaware Bans Trail Cameras for Recreational Use
    06/01/2023
    Check out The Newly Refurbished Haynes Park In Wilmington
    06/05/2023
    Leaders, NFL Legends to Launch New Child Identification Program in Delaware
    05/26/2023
  • Health
    HealthShow More
    Delaware Officials Provide Latest Updates, Underscore Urgency Surrounding Youth, Opioids, and Prevention Programs 
    06/01/2023
    What You need To Know About COVID-19 Treatment Options
    03/17/2023
    Stray cat in Newark tested positive for rabies, here’s what you need to know
    05/01/2021
    Division of Public Health closes it’s Bureau of Oral Health and Dental Services
    04/15/2021
    ChristianaCare named one of America’s 50 Best Hospitals in The U.S.
    02/10/2021
  • Politics
    Politics
    Delaware Newsline is a digital Delaware News Organization that provides local and national breaking news content to its Delaware and U.S. audience, by utilizing multiple…
    Show More
    Top News
    Watch: Governor Carney’s Easter Message For Delawareans
    10/06/2022
    What you need to know about Delaware’s in-person voting
    10/07/2022
    Delaware high school students are graduating at their highest levels in at least a decade
    10/07/2022
    Latest News
    Senator Tom Carper (D) Will Not Be Seeking Another Term In 2024
    05/22/2023
    Why Governor Carney Did Not Sign HB1, HB2, Legalizing Recreational Marijuana 
    04/24/2023
    Governor Carney Plans to End Public Health Emergency Order in May
    04/07/2023
    Delaware Lt. Governor Bethany Hall-Long Receives National Recognition
    04/06/2023
  • Sports
    Sports
    Delaware Newsline strives to be radically engaged in its communities. You may see us at protests, press releases, community gatherings, and of course at breaking…
    Show More
    Top News
    Amid the pandemic, the Blue & Gold All-Star Football Game is cancelled
    10/06/2022
    SEPTA from Wilmington to the Eagles parade in Philadelphia, yes, you can do that!
    10/08/2022
    Delaware to achieve the goals of expanding Unified sports Schools programming
    10/07/2022
    Latest News
    Summer Games For Special Olympics Kicks Off Saturday June 9, 2023
    06/04/2023
    DFRC Blue-Gold 2023 Player Rosters Announced
    04/06/2023
    Blue Coats To Host Blue Bombers Tribute
    03/14/2023
    Amid the pandemic, the Blue & Gold All-Star Football Game is cancelled
    10/06/2022
  • Traffic
    TrafficShow More
    Tractor Trailer Fire Shuts Down I-295 NB On The Delaware Memorial Bridge Tuesday Night
    05/31/2023
    Maryland Police Officer Injured After Being Struck Head-On By Drunk Driver
    05/30/2023
    24-Year-Old Man Dies Following Fatal Middletown Crash
    05/26/2023
    Police Investigating Serious Crash On Commons Blvd Thursday Night
    05/25/2023
    Man Charged After Crashing Into Wilmington Police Vehicle That flipped On It’s Side Monday Night
    05/23/2023
  • Weather
  • DNTV
  • Join Us
  • More
Reading: BioTech Moderna requests emergency authorization for Covid-19 Vaccine
Share
Aa
DNTVDNTV
  • Entertainment
  • Technology
Search
  • Home
  • Categories
    • Technology
    • Entertainment
    • Health
  • Bookmarks
    • Customize Interests
    • My Bookmarks
  • More Foxiz
    • Blog Index
    • Sitemap
Have an existing account? Sign In
Follow US
DNTV > Blog > Coronavirus > BioTech Moderna requests emergency authorization for Covid-19 Vaccine
Coronavirus

BioTech Moderna requests emergency authorization for Covid-19 Vaccine

George Shea
Last updated: 2022/11/20 at 4:55 AM
George Shea Published 11/29/2020 73 Views
Share
11 Min Read
PHOTO COURTESY | Photo by Gustavo
SHARE
- Support Us -
Ad imageAd image

Moderna plans to request an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) and conditional approval from the European Medicines Agency (EMA).

CAMBRIDGE (MA): Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that the primary efficacy analysis of the Phase 3 study of mRNA-1273 conducted on 196 cases confirms the high efficacy observed at the first interim analysis.

The data analysis indicates a vaccine efficacy of 94.1%. Safety data continue to accrue and the study continues to be monitored by an independent, NIH-appointed Data Safety Monitoring Board (DSMB).

The Company also announced that today, Moderna plans to request an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) and conditional approval from the European Medicines Agency (EMA).

The Phase 3 study, known as the COVE study, enrolled more than 30,000 participants in the U.S. and is being conducted in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services.

The primary endpoint of the Phase 3 COVE study is based on the analysis of COVID-19 cases confirmed and adjudicated starting two weeks following the second dose of vaccine.

Photo Courtesy of | Michelangelo Buonarroti

Vaccine efficacy has been demonstrated at the first interim analysis with a total of 95 cases based on the pre-specified success criterion on efficacy.

- Advertisement -
Ad image

Today’s primary analysis was based on 196 cases, of which 185 cases of COVID-19 were observed in the placebo group versus 11 cases observed in the mRNA-1273 group, resulting in a point estimate of vaccine efficacy of 94.1%.

A secondary endpoint analyzed severe cases of COVID-19 and included 30 severe cases (as defined in the study protocol) in this analysis. All 30 cases occurred in the placebo group and none in the mRNA-1273 vaccinated group.

There was one COVID-19-related death in the study to date, which occurred in the placebo group.

Efficacy was consistent across age, race and ethnicity, and gender demographics.

The 196 COVID-19 cases included 33 older adults (ages 65+) and 42 participants identifying as being from diverse communities (including 29 Hispanic or LatinX, 6 Black or African Americans, 4 Asian Americans and 3 multiracial participants).

The safety profile of the Phase 3 study of mRNA-1273 was previously described on November 16. A continuous review of safety data is ongoing and no new serious safety concerns have been identified by the Company. Based on prior analysis, the most common solicited adverse reactions included injection site pain, fatigue, myalgia, arthralgia, headache, and erythema/redness at the injection site. Solicited adverse reactions increased in frequency and severity in the mRNA-1273 group after the second dose.

The Company will submit data from the Phase 3 COVE study to a peer-reviewed publication.

“This positive primary analysis confirms the ability of our vaccine to prevent COVID-19 disease with 94.1% efficacy and importantly, the ability to prevent severe COVID-19 disease. We believe that our vaccine will provide a new and powerful tool that may change the course of this pandemic and help prevent severe disease, hospitalizations and death,” said Stéphane Bancel, Chief Executive Officer of Moderna.

“We will file today for an Emergency Use Authorization from the FDA and continue forging ahead with the rolling reviews that have already been initiated with several regulatory agencies around the globe.,” Bancel added.

Additionally, Moderna announced that the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting to review the safety and efficacy data package for mRNA-1273 will likely be scheduled for Thursday, December 17.

The Company expects that the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) will make a recommendation on immunization priorities.

The Company anticipates that the shipping of mRNA-1273 to designated distribution points throughout the U.S. will occur shortly after an Emergency Use Authorization is granted.

Moderna is working with the U.S. CDC, Operation Warp Speed and McKesson (NYSE: MCK), a COVID-19 vaccine distributor contracted by the U.S. government, as well as global stakeholders to be prepared for distribution of mRNA-1273, in the event that it receives an EUA and similar global authorizations and approvals.

By the end of 2020, the Company expects to have approximately 20 million doses of mRNA-1273 available in the U.S.

The Company remains on track to manufacture 500 million to 1 billion doses globally in 2021. On November 10, the American Medical Association (AMA) issued a Current Procedural Terminology (CPT) code to report vaccination with mRNA-1273 (code: 91301). Moderna recently announced further progress towards ensuring the distribution, storage and handling of the vaccine can be done using existing infrastructure.

[su_tabs]

[su_tab title=”About the Phase 3 COVE Study”]

The Phase 3 COVE trial is a randomized, 1:1 placebo-controlled study testing mRNA-1273 at the 100 µg dose level in 30,000 participants in the U.S., ages 18 and older. The primary endpoint is the prevention of symptomatic COVID-19 disease. Key secondary endpoints include prevention of severe COVID-19 disease and prevention of infection by SARS-CoV-2. The trial will continue to accrue additional data relevant to safety and efficacy even after an EUA is submitted. The final estimates of vaccine efficacy for both primary and secondary endpoints will depend on the totality of data that will accumulate to inform the final analysis. Moderna worked closely with BARDA and the NIH, including NIAID’s COVID-19 Prevention Network (CoVPN), to conduct the Phase 3 COVE study under Operation Warp Speed. Moderna’s partner PPD (Nasdaq: PPD), a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services, has also been essential to the successful execution of the COVE study.

The Phase 3 COVE study was designed in collaboration with the FDA and NIH to evaluate Americans at risk of severe COVID-19 disease and completed enrollment of more than 30,000 participants ages 18 and older in the U.S. on October 22, including those at high risk of severe complications of COVID-19 disease. The COVE study includes more than 7,000 Americans over the age of 65. It also includes more than 5,000 Americans who are under the age of 65 but have high-risk chronic diseases that put them at increased risk of severe COVID-19, such as diabetes, severe obesity and cardiac disease. These medically high-risk groups represent 42% of the total participants in the Phase 3 COVE study. The study also included communities that have historically been under-represented in clinical research and have been disproportionately impacted by COVID-19. The study includes more than 11,000 participants from communities of color, representing 37% of the study population, which is similar to the diversity of the U.S. at large. This includes more than 6,000 participants who identify as Hispanic or LatinX, and more than 3,000 participants who identify as Black or African American.

[/su_tab]

[su_tab title=”About mRNA-1273″]

mRNA-1273 is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein, which was co-developed by Moderna and investigators from NIAID’s Vaccine Research Center. The first clinical batch, which was funded by the Coalition for Epidemic Preparedness Innovations, was completed on February 7, 2020 and underwent analytical testing; it was shipped to the NIH on February 24, 42 days from sequence selection. The first participant in the NIAID-led Phase 1 study of mRNA-1273 was dosed on March 16, 63 days from sequence selection to Phase 1 study dosing. On May 12, the FDA granted mRNA-1273 Fast Track designation. On May 29, the first participants in each age cohort: adults ages 18-55 years (n=300) and older adults ages 55 years and above (n=300) were dosed in the Phase 2 study of mRNA-1273. On July 8, the Phase 2 study completed enrollment.

Results from the second interim analysis of the NIH-led Phase 1 study of mRNA-1273 in the 56-70 and 71+ age groups were published on September 29 in The New England Journal of Medicine. On July 28, results from a non-human primate preclinical viral challenge study evaluating mRNA-1273 were published in The New England Journal of Medicine. On July 14, an interim analysis of the original cohorts in the NIH-led Phase 1 study of mRNA-1273 was published in The New England Journal of Medicine. mRNA-1273 currently is not approved for use by any regulatory body.

BARDA is supporting the continued research and development of mRNA-1273 with $955 million in federal funding under Contract no. 75A50120C00034. BARDA is reimbursing Moderna for 100 percent of the allowable costs incurred by the Company for conducting the program described in the BARDA contract. The U.S. government has agreed to provide up to $1.525 billion to purchase supply of mRNA-1273 under U.S. Department of Defense Contract No. W911QY-20-C-0100. [/su_tab][/su_tabs]

- Support Us -
Ad imageAd image

You Might Also Like

FDA Authorizes Changes To Simplify Use Of Bivalent mRNA Covid-19 Vaccines

Mask mandate requires masks to be worn in schools regardless of vaccination status

Unvaccinated Delawareans now account for 99% of the COVID-19 cases

Following a surge of cases, testing guidelines updated for the unvaccinated

CDC issues new mask guidelines for vaccinated Americans

TAGGED: Coronavirus Vaccine

Subscribe To Web Push Notifications And Get Real Time News Alerts On The Stories That Matter The Most To You!

Stay In Touch! Subscribe To Web Push Notifications And Get Real Time News Alerts On The Stories That Matter The Most To You! Best Of All, You're In Control and can unsubscribe at any time. So What are you waiting for, click the bell icon on the right at the bottom of your browser to get started!
George Shea 11/20/2022 11/29/2020
Share This Article
Facebook Twitter Reddit Email Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Happening Now

Breaking
Local
National
Breaking

Breaking

Police Investigating Shooting At Paradise Bar & Grill In Long Neck

Man Shot And Injured During Road Rage Incident Near Old Baltimore Pike
Breaking 06/03/2023
Police Investigating Shots Fired At Large Party Friday Night
Breaking 06/03/2023
Wilmington Man Arrested For Rape Of 12-Year-Old Girl
Breaking 06/02/2023

Local

Local News

In spite of not having a newspaper photographer, the William Penn HS Graduation Ceremony Still Went On

Delaware Bans Trail Cameras for Recreational Use
Local News 06/01/2023
Check out The Newly Refurbished Haynes Park In Wilmington
Local News 06/01/2023
Leaders, NFL Legends to Launch New Child Identification Program in Delaware
Local News 05/25/2023

National

National

Convicted Spy & Former FBI Agent, Robert Hanssen Found Dead In His Cell

Mass Shooting: 2 Killed, 12 others injured at New Jersey House Party
National 05/23/2021
Seven charged in federal court in connection with U.S. Capitol violence
National 01/13/2021
Court blocks Trump effort to exclude undocumented immigrants
National 09/12/2020

- Advertisement -
Ad imageAd image
Environmental
Weather
Traffic
Environmental

Environmental

Burning of Brush, Branches and Limbs Allowed in Delaware Until May 1

Deadly species of hemlock recently found in Sussex County by DNREC
Environmental 07/02/2021
Did you know these students cleanup Deemers Beach in New Castle every Saturday?
Environmental 04/20/2021
One ton of plastic bags will be made into benches by Eco Plastic DNREC says
Environmental 04/15/2021

Weather

BreakingWeather Alerts

Severe Storms On The Way

More Details Released On Saturday’s Tornado Event
Weather & Infrastructure 04/04/2023
Governor Carney Surveys Devastating Tornado Damage In Sussex County
Breaking Weather & Infrastructure 04/02/2023
Watch The moment When A tornado Touched Down in Sussex County
Weather & Infrastructure 04/02/2023

Traffic

Traffic

Tractor Trailer Fire Shuts Down I-295 NB On The Delaware Memorial Bridge Tuesday Night

Maryland Police Officer Injured After Being Struck Head-On By Drunk Driver
Traffic 05/30/2023
24-Year-Old Man Dies Following Fatal Middletown Crash
Traffic 05/26/2023
Police Investigating Serious Crash On Commons Blvd Thursday Night
Traffic 05/25/2023

- Advertisement -
Ad imageAd image
Social Justice
Crime
Courts
Social Justice

Social Justice

Recap of the George Floyd Protest In Wilmington

DOJ Releases Report On Wilmington Police Shooting of Jeremy McDole
Social Justice 09/23/2020
Mayor says community relations is his top priority in upcoming term
Social Justice 09/18/2020
Last Delaware “Whipping Post” to be removed from Georgetown
Social Justice 06/30/2020

Crime

Crime

Police Arrest Man For Swatting Incident That Disrupted Community, Resources, and First Responders

NCCPD, K9 Nova Locates three Suspects During An In-Progress Burglary
Crime 06/02/2023
Update: Arrest Made after Large Fight Erupts At Sussex Central H.S. Graduation Friday
Crime 06/01/2023
Three Teens Linked to Multiple New Castle Robberies
Crime 05/25/2023

Courts

Courts

Ex-Tower Hill employee sentenced for Child Pornography, Sexual Solicitation of a Child

Twenty Charged in Federal and State Court for Drug Conspiracy
Courts 05/28/2023
Lawsuit Filed Against New Castle County After Police Use Deadly Force Killing 22-Year-Old Man
Courts 05/28/2023
Guilty Plea Secured In 2019 Emma Cole Murder By Department Of Justice
Courts 05/25/2023

- Advertisement -
Ad image
Technology
Business
Space
Technology

Technology

Delmarva Power launches “Paint the tank” contest for high school students

Delmarva Power launches “Paint the tank” contest for high school students
Technology 04/18/2018
Two high-tech companies are taking their business to the next level
Technology 03/13/2018
Recreational DRONES and what you need to know about the legal stuff
Technology 11/25/2016

Business

Business

Mayor Purzycki Joins Lounge At Eighth In Ribbon Cutting Ceremony

Capitol One donates it’s $4 million dollar building to Delaware State University
Business 08/08/2021
New model healthcare opens at Wilmington’s Kingswood community center
Business 06/10/2021
Grand Opening At Next Generation Dunkin Donuts in New Castle
Business 04/01/2021

Space

Photo Courtesy Of NASA | Artist's concept of NASA's next-generation Lunar Terrain Vehicle on the surface of the Moon.
Space

If You Have A Lunar Terrain Vehicle, NASA Wants To Hear From You

NASA Mission to Study Ice Clouds, Help Observe Our Dynamic Atmosphere
Space 05/23/2023
NASA Names Astronauts to Next Moon Mission, First Crew Under Artemis
Space 03/30/2023
See Stunning Images of the NASA’s Perseverance Rover Mars Landing
Space 02/19/2021

FOLLOW US

592 Followers Like
349 Followers Follow
21 Followers Follow
66 Subscribers Subscribe
- Advertisement -
Ad imageAd image

More Stories

Most Read
  • From The Producer
  • Environmental
  • Entertainment
  • Community
  • Social Justice
  • Opinions
  • Climate
  • Crime
  • Courts
  • Space
  • Events

About DNTV/Delaware Newsline

Delaware Newsline is a digital Delaware News Organization that provides local and national breaking news content to its Delaware and U.S. audience, by utilizing multiple platforms including web, social media, and video.
Community Support
  • About DNTV/DN
  • Terms & Conditions
  • Report Story Errors
  • Report Infringement
  • Contact An Editor
Support Us Today
  • Submit A Donation
  • Subscription Plans
  • Submit A News Tips
  • Advertise With Us
Follow US
© 2016 Delaware Newsline/DNTV LIVE. All Rights Reserved.
  • Mapping Police Violence
  • Tracking Gun Violence
  • Tracking Cold Cases
  • Coronavirus
Subscribe For The Stories That Matter The Most

Stay In Touch! Get the latest news alerts delivered straight to your email. You can unsubscribe at any time.


Loading
Zero spam, Unsubscribe at any time.
adbanner
AdBlock Detected
Our site is an advertising supported site. Please whitelist to support our site.
Okay, I'll Whitelist

Insert/edit link

Enter the destination URL

Or link to existing content

    No search term specified. Showing recent items. Search or use up and down arrow keys to select an item.